Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Developmental Therapeutics

ESMO-Congress-2023-Banner-1000x250px

Friday 20 October

Are Brain Cancer Patients Finally Able to Benefit from Precision Medicine Approaches?

06-Are-Brain-Cancer-Patients-Finally-Able-to-Benefit-from-Precision-Medicine-Approaches-SERVIER-Thumb

Friday, 10:15 - 11:45
View the satellite invitation

Rethinking Cancer Therapies: Fresh Perspectives on MDM2-p53, HER2, DLL3 and Other Targets in Cancer

11-Rethinking-Cancer-Therapies-Fresh-Perspectives-BOEHRINGER-thumb

Friday, 18:00 - 19:30
View the satellite invitation

Sunday 22 October

ADCs’ Potential Across Tumors

38-ADCs-Potential-Across-Tumors-SEAGEN-Thumb

Sunday, 18:30 - 20:00
View the satellite invitation

The Multi-Tumor Toolkit: ADCs in Cancer Therapy

44-The-Multi-Tumor-Toolkit-ADCs-in-Cancer-Therapy-DAIICHI-SANKYO-thumb

Sunday, 18:30 - 20:00
View the satellite invitation

Monday 23 October

The Evolving Role of TTFields Therapy in Solid Tumors

51-The-Evolving-Role-of-TTFields-Therapy-in-Solid-Tumors-NOVOCURE-thumb

Monday, 13:00 - 14:30
View the satellite invitation

Shaping the Future of Personalised Healthcare for Cancer Patients

55-Shaping-the-Future-of-Personalised-Healthcare-for-Cancer-Patients-ROCHE-thumb

Monday, 18:30 - 20:00
View the satellite invitation

Please note: The European Society for Medical Oncology (ESMO) does not endorse any of the companies, or their products/services, that have sponsored these links.